Stryker Corporation

NYSE:SYK

Medical - Devices

Healthcare
$318.15 +3.08%

+$9.29 today

Market cap
$121.12B
Beta
0.79
P/E (TTM)
35.6
EPS (TTM)
$8.72
Dividend yield
1.11%
52W Low $281.00High $404.87

Volume 3.25M

Average 2.49M

SYK Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Stryker CorporationNYSE: SYK

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue dips below year-ago levels

Q2 FY2026 cost of revenue of $2.09B fell 0.9% year over year, behind the +1.8% change in trailing-twelve-month cost of revenue. Sequentially, it fell 5.4% from the prior quarter. Over 3 fiscal years it compounded at +6.9% a year.

Context

  • Cost of revenue amounted to 36.0% of revenue in FY2025, up 0.4 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -0.9% toward the trailing-twelve-month pace of +1.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$2.09B-5.4% QoQ
Last fiscal yearDec 2025
$9.05B+12.4% YoY
LTMJun 2026
$9B+1.8% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.9%——
1 year+12.4%——
3-year CAGR+6.9%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
9.05B USD
Year-over-year change
+12.4%
4-year CAGR
+9.1%

Cost of Revenue vs competitors

How SYK compares with its peers on the latest reported figures

  • SYK's LTM Jun 2026 cost of revenue of $9B is the 2nd highest of the 11 companies compared; the peer median is $876.71M.
  • Its year-over-year change of +1.8% is the 7th highest of 11, against a peer median of +3.6%.
  • Cost of revenue amounts to 34.8% of revenue for SYK, versus a peer median of 34.0%.
SYK Competitors Peer median
Cost of Revenue for SYK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$12.51B +0.0%+5.9%33.3%
SYKStryker CorporationLTM Jun 2026$9B +1.8%+6.9%34.8%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$2.56B +13.1%+16.1%30.1%
SNNSmith & Nephew plcFY2025$1.96B +13.1%+8.9%31.7%
GMEDGlobus Medical, Inc.LTM Jun 2026$989.14M +1.1%+53.7%31.5%
ENOVEnovis CorporationLTM Apr 2026$983.94M +5.2%+9.2%43.2%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$769.47M +2.0%+10.4%46.8%
CNMDCONMED CorporationLTM Mar 2026$636.88M +8.8%+11.0%46.4%
ATECAlphatec Holdings, Inc.LTM Mar 2026$272.95M +36.9%+25.4%34.7%
OFIXOrthofix Medical Inc.LTM Mar 2026$255.74M -3.2%+29.9%31.0%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$45.91M -10.2%+24.3%37.7%
Peer median (excluding SYK) $876.71M+3.6%+13.6%34.0%

Competitors are the stored peer set for SYK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.11B18.45B20.5B22.6B25.12B
Cost of Revenue6.4B7.41B8B8.05B9.05B
Gross Profit10.71B11.04B12.49B14.55B16.07B
Gross Margin62.6%59.8%61.0%64.4%64.0%
Research & Development1.13B1.23B1.29B1.47B1.58B
Selling, General & Admin5.81B6.08B6.92B7.5B8.65B
Operating Expenses6.95B7.31B8.21B10.86B11.18B
Depreciation & Amortization990M998M1.03B1.05B1.19B
EBITDA3.61B4.02B5.06B6.01B6.31B
EBITDA Margin21.1%21.8%24.7%26.6%25.1%
Operating Income3.76B3.73B4.28B3.69B4.89B
Operating Margin22.0%20.2%20.9%16.3%19.5%
Interest Income68M94M75M139M121M
Interest Expense337M337M356M396M607M
Other Income / Expenses(1.48B)(1.05B)(608M)(197M)(375M)
Income Before Tax2.28B2.68B3.67B3.49B4.51B
Pre-Tax Margin13.3%14.5%17.9%15.5%18.0%
Income Tax Expense287M325M508M499M1.27B
Net Income1.99B2.36B3.17B2.99B3.25B
Net Margin11.7%12.8%15.4%13.2%12.9%
EPS (Basic)5.296.238.347.868.49
EPS (Diluted)5.226.178.257.768.40
Weighted Avg Shares377M378.2M379.6M381M382.2M
Weighted Avg Shares (Diluted)382.3M382.2M383.7M385.6M382.2M

Stryker Corporation

NYSE:SYK

Intrinsic Alpha fair value

Locked

Current Price

$318.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.